en
Scientific article
English

Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children

ContributorsRudin, Christoph; Wolbers, Marcel; Nadal, David; Rickenbach, Martin; Bucher, Heiner C; the Pediatric Infectious Disease Group of Switzerland (PIGS); the Swiss Mother and Child HIV Cohort Study (MoCHiV)
Published inArchives of disease in childhood, vol. 95, no. 6, p. 478-481
Publication date2010
Abstract

To evaluate the long-term safety and effectiveness of lopinavir/ritonavir (LPV/r) in a population-based cohort of HIV-1-infected children.

Keywords
  • Adolescent
  • CD4 Lymphocyte Count
  • Child
  • Child, Preschool
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • HIV Infections/drug therapy/immunology/virology
  • HIV Protease Inhibitors/adverse effects/therapeutic use
  • HIV-1/isolation & purification
  • Humans
  • Lopinavir
  • Male
  • Prospective Studies
  • Pyrimidinones/adverse effects/therapeutic use
  • Ritonavir/adverse effects/therapeutic use
  • Treatment Outcome
  • Viral Load
Citation (ISO format)
RUDIN, Christoph et al. Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children. In: Archives of disease in childhood, 2010, vol. 95, n° 6, p. 478–481. doi: 10.1136/adc.2009.169375
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0003-9888
614views
0downloads

Technical informations

Creation09/09/2014 2:02:00 PM
First validation09/09/2014 2:02:00 PM
Update time03/14/2023 10:12:56 PM
Status update03/14/2023 10:12:55 PM
Last indexation01/16/2024 2:18:35 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack